- $12.13bn
- $26.37bn
- $5.51bn
- 55
- 66
- 51
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 5,209 | 4,682 | 4,900 | 5,851 | 5,505 |
Cost of Revenue | |||||
Operations & Maintenance | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,318 | 4,374 | 3,893 | 4,585 | 4,210 |
Operating Profit | 891 | 307 | 1,007 | 1,266 | 1,296 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 507 | -31.3 | 707 | 956 | 814 |
Provision for Income Taxes | |||||
Net Income After Taxes | 383 | -14.2 | 589 | 792 | 674 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 383 | -17.6 | 585 | 804 | 714 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 328 | -72.7 | 531 | 751 | 663 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.71 | 0.917 | 1.29 | 1.5 | 1.48 |
Dividends per Share |